Skip to content

US · MBAI · MEDICAL - DIAGNOSTICS & RESEARCH

Check-Cap Ltd. Ordinary Share (MBAI) intrinsic value and stock valuation

$2.00as of 2026-11-21 · Mkt cap 9.13M

Data updated · price as of 2026-11-21

IC valuationIntrinsic value, upside vs price and the fair-value band are available to Pro members.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

Check-Cap Ltd. Ordinary Share DCF and intrinsic value

InvestorsCraft values MBAI with the Chepakovich two-stage DCF model. How the model works · Run your own DCF prefilled from MBAI’s statements →

Check-Cap Ltd. Ordinary Share Graham Number

Graham Number: $2.87d — the price is at or below the Graham Number. Formula √(22.5 × EPS × BVPS) using the latest diluted EPS and book value per share. Guide · Calculator →

Healthcare · Medical - Diagnostics & Research Isfiya, HA 3009000 check-cap.com

How the business is doing

Fiscal 2021–2025, USD

Revenue
$0.00
20212025
Net income
$4.14M
20212025
Free cash flow
-$-50K
20212025
Total equity
$3.44M
20212025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Financials

Statements by fiscal year

Fiscal 2021–2025, USD
20252024202320222021
Revenue$0.00$0.00$0.00$0.00$0.00
Operating income-$-2.37M-$-25.95M-$-19.29M-$-20.03M-$-17.32M
Net income$4.14M-$-25.15M-$-17.57M-$-19.11M-$-17.2M
EPSd$664.5K-$-4.3M-$-3M-$-3.37M-$-3.03M
Operating cash flow-$-50K-$-8M-$-16.95M-$-18.71M-$-16.26M
Capital expenditure$0.00$0.00-$-80K-$-490K-$-1.01M
Free cash flow-$-50K-$-8M-$-17.04M-$-19.19M-$-17.27M
Total assets$7.49M$380K$25M$45.4M$55.7M
Total debt$20K$140K$0.00$960K$1.15M
Net debt$10K$140K-$-8.84M-$-3.13M-$-25.31M
Total equity$3.44M-$-1.45M$23.7M$41.3M$50.7M
Cash and short-term investments$220K$270K$24.8M$41.7M$51.6M
Income statement
20252024202320222021
Revenue$0.00$0.00$0.00$0.00$0.00
Cost of revenue$0.00$0.00$0.00$0.00$0.00
Gross profit$0.00$0.00$0.00$0.00$0.00
Research and development expenses$0.00$0.00$8.31M$14.3M$12.4M
Selling, general and administrative expenses$2.34M$9.3M$9.46M$5.65M$4.94M
Other expenses$30K$16.7M$1.51M$120K$40K
Operating expenses$2.37M$26M$19.3M$20M$17.3M
Cost and expenses$2.37M$26M$19.3M$20M$17.3M
Interest income$170K$810K$1.77M$1.05M$100K
Interest expense$180K$10K$10K$10K$10K
Depreciation and amortization$30K$160K$210K$400K$200K
Ebitda$4.36M-$-24.98M-$-17.34M-$-18.69M-$-16.98M
Operating income-$-2.37M-$-25.95M-$-19.29M-$-20.03M-$-17.32M
Total other income/expenses, net$6.51M$800K$1.72M$930K$120K
Income before tax$4.14M-$-25.15M-$-17.57M-$-19.11M-$-17.2M
Income tax expense$0.00$0.00$0.00$0.00$0.00
Net income$4.14M-$-25.15M-$-17.57M-$-19.11M-$-17.2M
Weighted average shares outstanding$6.23M$5.85M$5.85M$5.67M$5.67M
Weighted average diluted shares outstanding$6.23M$5.85M$5.85M$5.67M$5.67M
Balance sheet
20252024202320222021
Cash and short-term investments$220K$270K$24.8M$41.7M$51.6M
Net receivables$0.00$0.00$0.00$0.00$0.00
Inventory$0.00$0.00$0.00$0.00$0.00
Total current assets$220K$270K$24.9M$42.6M$52.8M
Property, plant and equipment, net$20K$110K$160K$2.81M$2.91M
Goodwill and intangible assets$730K$0.00$0.00$0.00$0.00
Long-term investments$6.53M$0.00$0.00$0.00$0.00
Total non-current assets$7.27M$110K$160K$2.81M$2.91M
Total assets$7.49M$380K$25M$45.4M$55.7M
Accounts payable$790K$490K$140K$950K$1.05M
Short-term debt$20K$120K$0.00$340K$350K
Deferred revenue$0.00$0.00$0.00$0.00$0.00
Total current liabilities$4.05M$1.81M$1.33M$3.41M$4.04M
Long-term debt$0.00$20K$0.00$630K$800K
Deferred revenue, non-current$0.00$0.00$0.00$0.00$0.00
Total non-current liabilities$0.00$20K$0.00$720K$930K
Capital lease obligations$20K$140K$0.00$960K$1.15M
Total liabilities$4.05M$1.83M$1.33M$4.13M$4.97M
Common stock$83.9M$83.8M$83.8M$83.7M$68.8M
Retained earnings-$-165.87M-$-170.01M-$-144.86M-$-127.29M-$-108.19M
Accumulated other comprehensive income (loss)$0.00$0.00$0.00$0.00$0.00
Total equity$3.44M-$-1.45M$23.7M$41.3M$50.7M
Total investments$6.74M$270K$15.9M$37.6M$25.1M
Total debt$20K$140K$0.00$960K$1.15M
Net debt$10K$140K-$-8.84M-$-3.13M-$-25.31M
Cash flow statement
20252024202320222021
Net income$4.14M-$-25.15M-$-17.57M-$-19.11M-$-17.2M
Depreciation and amortization$30K$160K$210K$400K$200K
Stock-based compensation$0.00$10K-$-60K$880K$490K
Change in working capital-$-4.17M$480K-$-1.27M-$-260K$240K
Accounts receivable$0.00$0.00$0.00$0.00$0.00
Inventory$0.00$0.00$0.00$0.00$0.00
Accounts payable$2.22M$500K-$-850K$210K$360K
Net cash provided by operating activities-$-50K-$-8M-$-16.95M-$-18.71M-$-16.26M
Investments in property, plant and equipment$0.00$0.00-$-80K-$-490K-$-1.01M
Acquisitions, net$0.00$0.00$0.00$0.00$0.00
Net cash used for investing activities$50K-$-840K$21.4M-$-12.51M-$-16.01M
Common stock issued$0.00$0.00$0.00$8.85M$31.8M
Common stock repurchased$0.00$0.00$0.00$0.00$0.00
Dividends paid$0.00$0.00$0.00$0.00$0.00
Net cash used for financing activities$0.00$0.00$0.00$8.85M$51M
Net change in cash-$-50K-$-24.49M$4.4M-$-22.36M$18.8M
Cash at end of period$220K$270K$8.84M$4.44M$26.8M
Operating cash flow-$-50K-$-8M-$-16.95M-$-18.71M-$-16.26M
Capital expenditure$0.00$0.00-$-80K-$-490K-$-1.01M
Free cash flow-$-50K-$-8M-$-17.04M-$-19.19M-$-17.27M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Check-Cap Ltd. Ordinary Share

        Check-Cap Ltd. is a medical diagnostics entity currently in its clinical development phase, dedicated to advancing screening solutions that utilize capsule-based technology. This firm was established in 2004 and conducts its primary operations from Isfiya, Israel.

        CEO
        David Lontini
        Employees
        85
        Beta
        0.79

        Explore

        Frequently asked questions

        What is the intrinsic value of Check-Cap Ltd. Ordinary Share (MBAI)?

        InvestorsCraft does not currently publish an intrinsic value for MBAI. How the IC value is calculated.

        Is MBAI undervalued?

        InvestorsCraft does not publish an undervaluation signal for MBAI at this time.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.